Malzahn et al (14) and Tot (15) reported differences between p63, and CK5 and CK6 expression in breast carcinoma, where CK5 and CK6 were positive in 61% of the cases, compared with p63 that was expressed in 11% of the cases that were included in the study. The gene discussed is KRT5; the disease is breast carcinoma.